Affiliated partners in HIV/AIDS research across the Penn, CHOP, and Wistar campus include:
The Penn AIDS Clinical Trials Unit (ACTU) carries out clinical trials studying new treatments against HIV infection, AIDS, and AIDS-related opportunistic infections. The Penn ACTU is a member of the AIDS Clinical Trials Group supported by funds from the National Institute of Allergy and Infection Diseases (NIAID) in Washington, D.C.
The Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) is a consortium of more than 60 top HIV researchers from leading academic research institutions working with government, nonprofit organizations, and industry partners to test combinations of several novel immunotherapies under new preclinical research and clinical trials.
The Penn Mental Health AIDS Research Center (PMHARC) strives to transform how individuals with comorbid mental illness and HIV are treated and managed by developing innovative, interdisciplinary, and integrative approaches to optimize psychiatric, behavioral, and medical outcomes and achieving a better understanding of the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments.